Home » Newsletters » BioWorld

BioWorld

May 29, 2003

View Archived Issues

Compound Secures $12M Series A Round To Drive Adzyme Research

Compound Therapeutics Inc. has hit the ground running after closing a $12 million Series A round of financing.(BioWorld Today) Read More

Vivus Gets $17.5M In Private Placement To Push Products

Stem Cells Still Divisive; Senate Bill To Require Pediatric Trials

Awaiting Cialis Decision, ICOS Files $150M Shelf Registration

Other News To Note

Appointments And Advancements